The Claim

In adults with irritable bowel syndrome, baseline expectancy for peppermint oil is higher than for placebo, and only expectancy for peppermint oil correlates with symptom improvement in the double-blind group, indicating that placebo effects in this context are driven by specific treatment expectations rather than general optimism.

Source: Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
65score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

In adults with irritable bowel syndrome, higher expectations about peppermint oil are linked to symptom improvement, but higher expectations about a placebo are not. This suggests that the improvement seen with placebo is tied to specific beliefs about peppermint oil, not general positive attitudes.

See the scientific wording

In adults with irritable bowel syndrome, baseline expectancy for peppermint oil is higher than for placebo, but only expectancy for peppermint oil—not placebo—correlates with symptom improvement in the double-blind group, suggesting that placebo effects in this context may be driven by specific treatment expectations rather than general optimism.

Why this might work

When a person expects peppermint oil to help their stomach, their brain sends signals that calm overactive nerves in the gut, which reduces pain and discomfort.

Suggested mechanismbased on 1 study

What the research says

1 study
  1. Study: Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial

    The study measured baseline expectancy for both placebo and peppermint oil before randomization and found that only expectancy for peppermint oil correlated with improvement in the double-blind group, while expectancy for placebo did not correlate in the open-label group, suggesting specificity in expectation-driven effects.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.